Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 2
2008 4
2009 4
2010 5
2011 7
2012 5
2013 4
2014 5
2015 8
2016 4
2017 6
2018 7
2019 8
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

71 results
Results by year
Filters applied: . Clear all
Page 1
Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.
Muszbek N, Proudfoot C, Fournier M, Chen CI, Kuznik A, Kiss Z, Gal P, Michaud K. Muszbek N, et al. Among authors: Kuznik A. J Manag Care Spec Pharm. 2019 Nov;25(11):1268-1280. doi: 10.18553/jmcp.2019.25.11.1268. J Manag Care Spec Pharm. 2019. PMID: 31663465 Free article.
Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Ariëns LFM, Gadkari A, van Os-Medendorp H, Ayyagari R, Terasawa E, Kuznik A, Chen Z, Bégo-Le Bagousse G, Lu Y, Rizova E, Graham NMH, Pirozzi G, De Bruin-Weller M, Eckert L. Ariëns LFM, et al. Among authors: Kuznik A. Acta Derm Venereol. 2019 Sep 1;99(10):851-857. doi: 10.2340/00015555-3219. Acta Derm Venereol. 2019. PMID: 31099402 Free article.
Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses.
Choy E, Freemantle N, Proudfoot C, Chen CI, Pollissard L, Kuznik A, Van Hoogstraten H, Mangan E, Carita P, Huynh TM. Choy E, et al. Among authors: Kuznik A. RMD Open. 2019 Feb 18;5(1):e000798. doi: 10.1136/rmdopen-2018-000798. eCollection 2019. RMD Open. 2019. PMID: 30886733 Free PMC article. Review.
Bisphosphonates-much more than only drugs for bone diseases.
Kuźnik A, Październiok-Holewa A, Jewula P, Kuźnik N. Kuźnik A, et al. Among authors: Kuznik N. Eur J Pharmacol. 2020 Jan 5;866:172773. doi: 10.1016/j.ejphar.2019.172773. Epub 2019 Nov 6. Eur J Pharmacol. 2020. PMID: 31705903 Review.
71 results
Jump to page
Feedback